The Biden administration works around the clock to provide urgent assistance to India in its fight against mortals. COVID-19, including the identification and immediate availability of sources of raw materials that are urgently required for the Indian manufacture of the Covishield vaccine, the White House said on Sunday.
The United States decision came following a phone conversation between US National Security Advisor Jake Sullivan and his Indian counterpart Ajit Doval.
“Just as India sent aid to the United States because our hospitals were overloaded at the beginning of the pandemic, the United States is determined to help India in its time of need,” said Emily Horne, spokeswoman for the House National Security Council. Blanca after the phone call between Sullivan and Doval.
The Biden administration had been criticized by various quarters, including members and supporters of the Democratic Party, for failing to release surpluses. COVID-19 vaccinations to India as the country experiences its worst public health crisis.
India has urged the United States to supply the raw materials for the Indian manufacture of the Covidshield vaccine.
Expressing deep sympathy for the people of India following the recent increase in COVID-19 cases, Sullivan in the phone call affirmed the solidarity of the United States with India, the two countries with the highest number of COVID-19 cases in the world.
“Building on the seven-decade health partnership between the United States and India, including the battles against smallpox, polio, and HIV, they resolved that India and the United States will continue to fight against the COVID-19 pandemic together, ”Horne said.
Noting that the United States is working 24 hours a day to deploy available resources and supplies, Horne said that the United States has identified sources of specific raw material that are urgently required for Indian manufacture of the Covishield vaccine that will be available immediately. for India.
To help treat COVID-19 patients and protect frontline healthcare workers in India, the United States has identified supplies of therapeutic products, rapid diagnostic test kits, ventilators, and personal protective equipment (PPE) that will be immediately available to India.
Horne said the US is also looking for options to provide oxygen generation and related supplies on an urgent basis.
The US Development Finance Corporation (DFC) is funding a substantial expansion of the manufacturing capacity of BioE, the vaccine maker in India, allowing BioE to scale up to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022.
In addition, the United States is deploying an expert team of public health advisers from the Center for Disease Control (CDC) and USAID to work closely with the U.S. Embassy, Indian ministries of health, and Service personnel. of Epidemic Intelligence of India. USAID will also work quickly with CDC to support and accelerate the mobilization of emergency resources available to India through the Global Fund, he said.
India registered a record 3,49,691 new coronavirus infections on a day on Sunday, taking your total count of COVID-19 cases to 1,69,60,172.
The death toll rose to 1,92,311 with a record 2,767 new daily deaths, according to official data.
She is a freelance blogger, writer, and speaker, and writes for various entertainment magazines.